DrugPatentWatch Database Preview
Patent: 9,192,675
» See Plans and Pricing
Summary for Patent: 9,192,675
| Title: | Dry powder inhaler and system for drug delivery |
| Abstract: | A breath-powered, dry powder inhaler, a cartridge, and a pulmonary drug delivery system are provided. The dry powder inhaler can be provided with or without a unit dose cartridge for using with the inhaler. The inhaler and/or cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, peptides and proteins such as insulin and glucagon-like peptide 1 for the treatment of diabetes and/or obesity. The dry powder inhaler is compact; can be provided in various shapes and sizes, colors, and comprises a housing, a mouthpiece, a cartridge placement area, and a mechanism for opening and closing the medicament cartridge. The device is easy to manufacture, provides a pre-metered single unit dose, it is relatively easy to use, and can be reusable or disposable. |
| Inventor(s): | Smutney; Chad C. (Watertown, CT), Kinsey; P. Spencer (Sandy Hook, CT), Sahi; Carl R. (Coventry, CT), Adamo; Benoit (Mount Kisco, NY), Polidoro; John M. (Coventry, CT), McLean; Scott (Waterbury, CT), Overfield; Dennis (Fairfield, CT), Kraft; Kelly S. (Poughquag, NY), Somerville; Karla (Corona, CA) |
| Assignee: | ManKind Corporation (Valencia, CA) |
| Application Number: | 13/954,731 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,192,675
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | ManKind Corporation (Valencia, CA) | 2028-06-13 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Start Trial | ManKind Corporation (Valencia, CA) | 2028-06-13 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Start Trial | ManKind Corporation (Valencia, CA) | 2028-06-13 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | ManKind Corporation (Valencia, CA) | 2028-06-13 | RX | Orphan | search |
| Fresenius Kabi Usa | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017067 | 004 | 1973-03-05 | Start Trial | ManKind Corporation (Valencia, CA) | 2028-06-13 | RX | search | |
| Fresenius Kabi Usa | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017067 | 003 | 1973-03-05 | Start Trial | ManKind Corporation (Valencia, CA) | 2028-06-13 | RX | search | |
| Fresenius Kabi Usa | CHORIONIC GONADOTROPIN | gonadotropin, chorionic | INJECTABLE;INJECTION | 017067 | 002 | 1973-03-05 | Start Trial | ManKind Corporation (Valencia, CA) | 2028-06-13 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,192,675
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2004012672 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007033316 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007033372 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007121411 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2009055740 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2009055742 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2009152477 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
